GR 144053

Known as: GR-144053, GR144053 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
01219962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Essentials Collagen and thrombin when used simultaneously generate highly activated platelets. The effect of thrombin stimulation… (More)
Is this relevant?
2015
2015
BACKGROUND Under severe stenotic conditions, von Willebrand factor (VWF) multimerizes into large insoluble fibers at pathological… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
BACKGROUND AND PURPOSE Murine models of arterial thrombosis have gained utility with applications in genetically manipulated mice… (More)
Is this relevant?
2000
2000
To define the interaction of fibrinolytic components with platelets or coagulation factors on thrombus formation, we investigated… (More)
Is this relevant?
2000
2000
The interaction of fibrinolytic components with platelets or coagulation factors after endothelial injury, was investigated in… (More)
Is this relevant?
1999
1999
Microthrombi produced have a potential to form larger thrombi, leading to vascular occlusions. Recently, a new device to easily… (More)
Is this relevant?
1998
1998
BACKGROUND Citrated platelet-rich plasma (PRP) turbidimetry is used for assessing pharmacodynamic effects of glycoprotein (GP… (More)
  • figure 1
  • figure 2
  • table 2
  • table 1
Is this relevant?
1998
1998
The antithrombotic effect of GR144053, which inhibits platelet aggregation by binding to the fibrinogen receptor (glycoprotein… (More)
Is this relevant?
1997
1997
1. The present study investigated the inhibitory effect of losartan, a type 1 angiotensin II (AT1) antagonist, and of combined… (More)
Is this relevant?
1996
1996
We biochemically characterized a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venom. Flavostatin… (More)
Is this relevant?